Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12)

European Journal of Immunology

Volumn 32, Issue 8, 2002, Pages 2218-2228

  Laman, Jon D ^a   'T Hart, Bert A ^b   Brok, Herbert ^b   Van Meurs, Marjan ^a   Schellekens, Marc M ^c   Kasran, Ahmad ^d   Boon, Louis ^e   Bauer, Jan ^f   De Boer, Mark ^e   Ceuppens, Jan ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^c TNO   (Netherlands)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e Tanox Pharma BV   (Netherlands)

^f UNIVERSITY OF VIENNA   (Austria)

Author keywords

Autoimmunity; CD40; Dendritic cell; Immunotherapy; Multiple sclerosis

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MU5D12; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN FUNCTION; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CHRONIC INFLAMMATION; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG EFFICACY; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOID ORGAN; MALE; MONKEY; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTBRED STRAIN; PRIORITY JOURNAL; WHITE MATTER;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; CALLITHRIX; CROSS REACTIONS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MALE; MICE;

EID: 0036687834     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200208)32:8<2218::AID-IMMU2218>3.0.CO;2-0     Document Type: Article

References (33)

1. Experimental models of multiple sclerosis
2. Pathology of multiple sclerosis
3. CD40-CD40 ligand, interactions in experimental allergic encephalomyelitis and multiple sclerosis
4. Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus)
5. Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide
6. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis
7. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis
8. Accessory signaling by CD40 for T cell activation: Induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-γ production
9. The many roles of CD40 in cell-mediated inflammatory responses
10. Functions of CD40 and its ligand, gp39 (CD40L)
11. + T cells via CD40 ligand
12. Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: The encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule
13. A new primate model for multiple sclerosis in the common marmoset
14. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells
15. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction
16. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis
17. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate
18. Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: A correlative study in the experimental autoimmune marmosets (Callithrix jacchus)
19. Identification of autoantibodies associated with myelin damage in multiple sclerosis
20. Creation of a model for multiple sclerosis in Callithrix jacchus marmosets
21. The common marmoset: A new world primate species with limited MHC class II variability
22. T cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
23. Enhancement of T cell-independent immune responses in vivo by CD40 antibodies
24. Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis
25. CD40-CD40L interactions in atherosclerosis
26. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system
27. Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein
28. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
29. Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B-cell responses
30. Fractionation of central nervous system myelin proteins by reversed-phase high-performance liquid chromatography
31. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: A new view
32. New immunoenzyme-cytochemical stainings for the in situ detection of epitope specificity and isotype of antibody forming B cells in experimental and natural (auto) immune responses in animals and man
33. Double immunocytochemical staining for in vivo detection of epitope specificity and isotype of antibody-forming cells against synthetic peptides homologous to human immunodeficiency virus-1